Evidence map›Paper›PMID 40232335›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2025

Diagnostic performance of [

Jiucen Liang, Shaojuan Weng, Jing Zhang, Shuqin Jiang, Wen Li, Shuyi Li, Jian Rong, Hao Liu, Haipeng Chen, Zhidong Liu and 5 more

Registry-linked trialAbstract readClinical TrialComparative Study
PubMed Publisher
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05485792 (A Prospective Study on Comparison 18F-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Various Types of Cancer), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05485792 naunknown statusnot on this map

A Prospective Study on Comparison 18F-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Various Types of Cancer

TypeinterventionalSponsorAffiliated Cancer Hospital & Institute of Guangzhou Medical UniversityRan2022 to 2023Enrolled200ConditionsCancerArms18F-FAPI PET/CT and 18F-FDG PET/CT
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Clinical Evaluation of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. The value ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Diagnostic value of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. The predictive value ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jiucen Liang *Department of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Shaojuan Weng *Department of Institute of Cancer Research, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Jing Zhang *Department of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Shuqin JiangDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Wen LiDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Shuyi LiDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Jian RongDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, 30322, USA.
Hao LiuDepartment of Institute of Cancer Research, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Haipeng ChenDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Zhidong LiuDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Hao PengDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Sha YanDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China.
Rusen ZhangDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China. zhangrusen2015@163.com.
Steven H LiangDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, 30322, USA. steven.liang@emory.edu.
Linqi ZhangDepartment of Nuclear Medicine, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, P. R. China. zhanglinqi0909@163.com.ORCID 0000-0002-0607-6300

Funding

Guangdong Basic and Applied Basic Research Foundation 2024A1515011956Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University Clinical Research 5555 Program No. IIT-2022-015(HYX)National Natural Science Foundation of China No.82101994
6 · The paper itself

Abstract

purposeTo evaluate the diagnostic performance of [

methodsPatients with suspected HCC recurrence after resection or local-regional therapy, who underwent Ce-CT/MRI and [

resultsA total of 44 patients with 129 lesions were analyzed, of which 31 patients (91 lesions) were proved to be recurrent HCC and 38 lesions were TILs. On lesion-based analysis, the combination of [

conclusionsThe combination of [

trial registrationclinicaltrials.gov: NCT05485792.

Indexed as

Carcinoma, HepatocellularContrast MediaLiver NeoplasmsMagnetic Resonance ImagingNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMaleMiddle AgedProspective StudiesRecurrenceContrast Media[18F]FAPI-04 PET/CTContrast-enhanced CT/MRIHepatocellular carcinomaRecurrence

Identifiers

PMID40232335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.